Almanack Investment Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Almanack Investment Partners's AMGN Position: Q3 2023 in Review
Almanack Investment Partners sold out of Amgen (AMGN) in Q3 2023, closing a stake of 1,258 shares — an estimated $279K sold.
Almanack Investment Partners first reported a position in AMGN in Q2 2017 and held it in 19 quarters. The position peaked at $1.21M in Q2 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.
- Almanack Investment Partners reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
- Almanack Investment Partners sold 1,258 Amgen shares in Q3 2023, an estimated $279K.
- Almanack Investment Partners first reported a position in Amgen in Q2 2017 and held it in 19 quarters.
- Almanack Investment Partners's Amgen position peaked at $1.21M in Q2 2022.
- 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.
Based on Almanack Investment Partners's 13F filing for Q3 2023, filed 5 Oct 2023.